Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
January 13, 2023
The new year has hardly begun, but fears of a looming recession persist. Pandemic-era increases in health spending are unlikely to continue in low- and middle-income countries. Growing fiscal pressures—such as high debt, increasing interest rates, and declining foreign aid and revenues—bode ominous...
TESTIMONY
December 13, 2022
On December 13th 2022, CGD Senior Fellow Prashant Yadav appeared before the House Foreign Affairs Subcommittee on International Development, International Organizations, and Global Corporate Social Impact at a hearing titled “Modernizing International Development Assistance: Opportunities and Challe...
CGD NOTES
November 29, 2022
The importance of semiconductors to the functioning of so many activities was brought home when the COVID-19 pandemic disrupted production and trade. The shortage of semiconductors forced a cutback in the output of vehicles, consumer durables, and electronic equipment of all kinds, inflicting heavy ...
Blog Post
November 28, 2022
In August, Secretary of State Antony Blinken unveiled the administration’s new US Strategy Toward Sub-Saharan Africa. His remarks underscored the pivotal role Africa will play in shaping the future of the world and acknowledged that tackling the shared priorities of the United States and African cou...
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...
Blog Post
November 28, 2022
Building on the success of Operation Warp Speed, the US should deepen its engagement and ambition in global health R&D to drive transformative improvements in global health outcomes and security. Specifically, it should consider a subscription model for new antimicrobials; an advance market commitme...